Table 4.
DAVID enrichment analysis
| Term | P-value | Adjusted1 P-value |
|---|---|---|
| 25(OH)D-associated genes | ||
| Defense response to bacterium | <0.001 | 0.024 |
| Defense response | <0.001 | 0.026 |
| Response to bacterium | <0.001 | 0.130 |
| Serine-type endopeptidase activity | <0.001 | 0.022 |
| Serine-type peptidase activity | <0.001 | 0.022 |
| IFNB-1b-associated genes | ||
| Defense response | <0.001 | <0.001 |
| Response to wounding | <0.001 | <0.001 |
| Inflammatory response | <0.001 | <0.001 |
| Regulation of apoptosis | <0.001 | 0.004 |
| Regulation of programmed cell death | <0.001 | 0.005 |
| GEL-associated genes | ||
| Defense response | <0.001 | 0.001 |
| Inflammatory response | <0.001 | 0.095 |
| MHC class I protein complex | <0.001 | 0.100 |
| Antigen processing and presentation | <0.001 | 0.140 |
| Regulation of I-kappaB kinase/NF-kappaB cascade | <0.001 | 0.140 |
DAVID, Database for Annotation, Visualization and Integrated Discovery; 25(OH)D, 25-hydroxyvitamin D; IFNB-1b, interferon beta-1b; GEL, gadolinium-enhancing lesions; MHC, major histocompatibility complex.
FDR corrected using the Benjamini and Hochberg (BH) adjustment.20